Inhibition of the Insulin-Like Growth Factor-1 Receptor Enhances Effects of Simvastatin on Prostate Cancer Cells in Co-Culture with Bone

By Nordstrand Annika   Lundholm Marie   Larsson Andreas   Lerner Ulf   Widmark Anders   Wikström Pernilla  

Cancer Microenvironment, Vol. 6, Iss. 3, 2013-12 ,pp. : 231-240

Springer Publishing Company

Access to resources Recommend Favorite

Decreased prostate cancer cell migration by inhibition of the insulin-like growth factor II/Mannose-6-Phosphate receptor - A receptor saturation mechanism to increase the secretion of lysosomal proenzymes

By Evans C.P.   Elfman F.   Cunha G.   Shuman M.A.  

Urologic Oncology: Seminars and Original Investigations, Vol. 3, Iss. 5, 1997-09 ,pp. : 166-170

Elsevier

Access to resources Recommend Favorite

Combined inhibition of insulin-like growth factor-1 receptor enhances the effects of gefitinib in a human non-small cell lung cancer resistant cell line

By Qi Hui wei   Shen Zan   Fan Li hong  

Experimental and Therapeutic Medicine, Vol. 2, Iss. 6, 2011-11 ,pp. : 1091-1095

Spandidos Publications

Access to resources Recommend Favorite

Growth Inhibition of Insulin-Like Growth Factor I Receptor Monoclonal Antibody to Human Colorectal Cancer Cells

By Zhang Youcheng   Zhang Yawu  

Cancer Investigation, Vol. 26, Iss. 3, 2008-01 ,pp. : 230-236

Informa Healthcare

Access to resources Recommend Favorite

Clinical Phase I study with an Insulin-like Growth Factor-1 Receptor Inhibitor: Experiences in patients with squamous non-small cell lung carcinoma

By Ekman Simon   Fröödin Jan-Erik   Harmenberg Johan   Bergman Antonina   Hedlund ÅÅsa   Dahg Pia   Alvfors Carina   Stååhl Birgitta   Bergströöm Stefan   Bergqvist Michael  

Acta Oncologica, Vol. 50, Iss. 3, 2011-04 ,pp. : 441-447

Informa Healthcare

Access to resources Recommend Favorite